Evidence map›Paper›PMID 40385968›Full record

ArticleEndoscopic ultrasound

EUS-guided portal pressure gradient measurement for evaluating the severity of portal hypertension: A retrospective analysis.

Rongkun Luo, Mingcong Chen, Huanyuan Lu, Rui Zhang, Hongwu Luo, Yinghong Liu, Xunyang Liu, Feizhou Huang, Gang Deng, Zhao Lei

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Endoscopic ultrasound. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Review
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Rongkun LuoDepartment of Hepatobiliary Surgery, The Third Xiangya Hospital of Central South University, Changsha 410013, Hunan Province, China.
Mingcong ChenDepartment of Pediatrics, The Third Xiangya Hospital of Central South University, Changsha 410013, Hunan Province, China.
Huanyuan LuDepartment of Hepatobiliary Surgery, The Third Xiangya Hospital of Central South University, Changsha 410013, Hunan Province, China.
Rui ZhangDepartment of Hepatobiliary Surgery, The Third Xiangya Hospital of Central South University, Changsha 410013, Hunan Province, China.
Hongwu LuoDepartment of Hepatobiliary Surgery, The Third Xiangya Hospital of Central South University, Changsha 410013, Hunan Province, China.
Yinghong LiuDepartment of Surgery Center, The Third Xiangya Hospital of Central South University, Changsha 410013, Hunan Province, China.
Xunyang LiuDepartment of Hepatobiliary Surgery, The Third Xiangya Hospital of Central South University, Changsha 410013, Hunan Province, China.
Feizhou HuangDepartment of Hepatobiliary Surgery, The Third Xiangya Hospital of Central South University, Changsha 410013, Hunan Province, China.
Gang DengDepartment of Hepatobiliary Surgery, The Third Xiangya Hospital of Central South University, Changsha 410013, Hunan Province, China.
Zhao LeiDepartment of Hepatobiliary Surgery, The Third Xiangya Hospital of Central South University, Changsha 410013, Hunan Province, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background and Objectives: EUS-guided portal pressure gradient (EUS-PPG) measurement has been proposed as a novel direct manometry to quantify portal hypertension. This study aimed to explore the ability of EUS-PPG measurements to evaluate the severity of portal hypertension. Methods: The clinical features of patients with diagnosed cirrhosis or chronic liver disease who underwent EUS-PPG measurement at a single center were retrospectively analyzed. The correlations between the clinical features of portal hypertension and the EUS-PPG measurements were analyzed, and then receiver operating characteristic curves were used to evaluate the ability of the EUS-PPG measurements to evaluate disease severity. Results: A total of 197 patients were included in this study. The EUS-PPG measurements varied significantly among patients categorized by gastroesophageal varices, red signs, variceal bleeding, ascites, hepatic encephalopathy, thrombocytopenia, hypoproteinemia, prothrombin time, international normalized ratio, or Child-Pugh grade ( Conclusions: EUS-PPG measurement seems to be an effective technique for assessing disease severity and risk of variceal bleeding in patients with diagnosed cirrhosis or chronic liver disease.

Indexed as

CirrhosisEUSPortal hypertensionPortal pressure gradient

Identifiers

PMID40385968
PMCPMC12080684

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.